Dana-Farber Cancer Institute: Immunotherapy may yield longer treatment-free survival than targeted therapy in advanced renal cell carcinoma patients

Press/Media

PeriodNov 10 2021

Media coverage

1

Media coverage

  • TitleDana-Farber Cancer Institute: Immunotherapy may yield longer treatment-free survival than targeted therapy in advanced renal cell carcinoma patients
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date11/10/21
    PersonsElizabeth R. Plimack
View all 1
View less